Written By: Stephen L Kanaval
Equities: One aspect of the company that’s really interesting to us here at Equities is Aurora’s partnership with Radient Technologies, which just received its standard processing license. How does Aurora envision this partnership going forward?
Marc Lakmaaker: “Radient is a very important partnership because we are looking at a global cannabis industry with huge market potential. The market is moving towards more innovative, smoke-free products. So, in order to build up capacity and meet the demands of what will be a dominant marketplace for years to come, you have to have capacity extraction.”
Equities: Regarding that, what is the key difference-maker in Radient’s technology?
Lakmaaker: “Where Radient comes in is that they have extraction technology that reduces process time from hours to minutes, so their throughput is going to be far higher than anything else available on the market right now. Beyond that, the technology allows you to basically extract the entire cannabinoid profile from the plant, so the extract has the same quality profile as the original plant. The technology gives us a lot of flexibility in terms of what products we can develop, and the capacity and the skill with which we can operate—all while keeping costs down and margins high. It is truly a partnership for the future, and we believe the partnership gives us a great competitive advantage.”
Equities: Tangential to Radient, how do you guys see Hemp playing a role in your portfolio and revenue stream going forward?
Lakmaaker:”In the cannabis market a year ago we were seeing mostly medical and consumer, and now we are seeing a medical and consumer market geared toward wellness. As the wellness part of this market continue to develop we will start to see a market that supplies a variety of non-prescription formulations that are driven by CBD-based products. That is really where hemp comes in, and already we own Agropro, the largest organic CBD hemp producer in Europe, Hemp Co., one of the largest hemp processors in Canada, and ICC Labs, which has substantial hemp assets in Latin America.”
Equities: Can you tell us more about ICC Labs?
Lakmaaker : “ICC is very interesting because they are able to grow hemp that is highly rich in CBD. In Canada and other places, you can only grow hemp that is up to 3% CBD, but in Uruguay it is much higher than that. And with the parallel research we are doing, we believe we will be able to launch a broad wellness product line. Bottom line, it is going to be a fascinating market and we are excited to have diverse distribution channels in which to distribute our products, and global research to back up everything we do..”
Equities: What does Aurora see on the international side of operations this year regarding potential milestones?
Lakmaaker: “It is very important for us to establish an early footprint and brand awareness in all these up-and-coming markets. What we are doing by virtue of being an early mover is we are engaging with the medical community in all of these countries. We are also engaging with the regulatory establishment in each market. Also, if you look at physicians, they are still among the largest drivers for growth in the medical space. So, if you look at the chemical work we are doing—all the case studies—all of these enable us to establish a very early footprint with the people who are actually making a difference in the market.”
Equities: Cannabis beverages will be a huge slice of the market. How do you see Aurora approaching this segment?
Lakmaaker: “Obviously, this is a space we are very interested in, and we have even indicated our interest in the past. We think it is going to be big and we look to be an important player in the space in terms of cannabis infusions and the wellness side.”
Equities: Thank you, Marc.
Use Hackathons to Go from Zero to Business Impact in a Week
Homer Simpson vs Mr. Burns
7 Ways to Effectively Lead a Team on Different Schedules
6 Things NOT to Do with Gatekeepers
How to Close Skill Gaps During Tech Disruption
How Do YOU Find Happiness at Work?
6 Ways to Marie Kondo Your Sales Process
Estate Planning in Second Marriages
Why Companies Should Focus on Employee Health
Retirement Medical Costs Not So Scary When Seen Yearly
Advisor11 hours ago
Homer Simpson vs Mr. Burns
Insights21 hours ago
Europe: The Good, the Bad and the Ugly
Markets21 hours ago
The Mad March Bounce
Development21 hours ago
Persevering Through Daily Mundane Is the Quickest Path to Success
Markets1 day ago
What’s Causing Investors to Come off of the Sidelines?
Sales Strategy1 day ago
7 Key Components When Selling to the C-Suite
Equities2 days ago
Should We break-up Facebook, Google, Amazon, Apple?
Global2 days ago
Don’t Be Fooled by the Politics of Envy